---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-377362"
form_type: "8-K"
ticker: "RVMD"
cik: "0001628171"
company_name: "Revolution Medicines, Inc."
filed_at: "2026-09-01T10:00:27+00:00"
generated_at: "2026-09-01T10:10:44.359163+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Revolution Medicines signs 4-building lease for new Redwood City HQ (672k sq ft, ~$2.7M/mo)

## Summary
- Leases for four Seaport Blvd buildings (1600-1900) totaling ~672,000 rentable sq ft as new HQ; effective subject to Phase II Closing.
- Commencement staggered Sep 26, 2027–Sep 1, 2028; initial terms end Sep 2042 with three 5-yr extension options.
- Aggregate base rent starts ~$2.7M/month at full commencement, +3% annually; rent abatement ~$23.1M through Jan 2030.
- Tenant improvement allowances ~$115.9M plus optional additional ~$40.3M (amortized at 10% annually as extra rent).
- Related-party: Farallon (owns ~6.4% of RVMD) indirectly owns majority of landlords; Leases create direct financial obligation.

## SEC filing metadata
- accession: 0001193125-26-377362
- form_type: 8-K
- ticker: RVMD
- cik: 0001628171
- company_name: Revolution Medicines, Inc.
- filed_at: 2026-09-01T10:00:27+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628171/000119312526377362/0001193125-26-377362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628171/000119312526377362/rvmd-20260827.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-377362
- JSON: https://secwatch.observer/filing/0001193125-26-377362.json
- Plain text: https://secwatch.observer/filing/0001193125-26-377362.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.